Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults
NCT02154308
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
787
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
IL-YANG FLU Vaccine Prefilled Syringe INJ 0.5mL
Sponsor
Il-Yang Pharm. Co., Ltd.